Skip to main content

Peer Review reports

From: A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report

Original Submission
9 Sep 2020 Submitted Original manuscript
12 Nov 2020 Reviewed Reviewer Report
16 Nov 2020 Reviewed Reviewer Report
11 Dec 2020 Author responded Author comments - Lijuan Jiang
Resubmission - Version 2
11 Dec 2020 Submitted Manuscript version 2
27 Feb 2021 Reviewed Reviewer Report
27 Feb 2021 Reviewed Reviewer Report
14 Jul 2021 Author responded Author comments - Lijuan Jiang
Resubmission - Version 3
14 Jul 2021 Submitted Manuscript version 3
Publishing
6 Aug 2021 Editorially accepted
23 Aug 2021 Article published 10.1186/s12894-021-00879-4

You can find further information about peer review here.

Back to article page